Latest News
3 Top Healthcare Stocks to Buy for July
Three medical device stocks that make solid long-term investments.
The Chart of the Day belongs to the healthcare company Merit Medical Systems (MMSI) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
Modern design advances patient care by combining hemostasis with innovative cooling capability...
Merit Medical Reports Results for Quarter Ended June 30, 2022
Q2 2022 reported revenue of $295.0 million, up 5.2% compared to Q2 2021Q2 2022 constant currency revenue, organic* up 7.4% compared to Q2 2021Q2 2022 GAAP...
Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need
Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions...
Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
SOUTH JORDAN, Utah, July 14, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of...
First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada
Prospective, observational study to assess the clinical utility of the SCOUT® Radar Localization System (SCOUT) in real-world practice...
New SCOUT® Mini Reflector Provides Physicians with a Compact Design for Greater Utility
Reduced profile designed to optimize use in lymph nodes and other difficult-to-localize areas and enable placement at time of biopsy or pre-neoadjuvant...
First Patient Enrolled in Merit Medical’s WRAPSODY™ Registry (WRAP) Study
Prospective, international, multicenter, observational study to assess the real-world safety and efficacy of the WRAPSODY Cell-Impermeable Endoprosthesis...
Merit Medical Celebrates Completion of Xeriscape Landscaping Project
Utah Governor and local officials joined Merit in recognizing green initiative to save 4 million gallons of water each year...
Merit Medical Reports Results for Quarter Ended March 31, 2022
Q1 2022 reported revenue of $275.4 million, up 10.6% compared to Q1 2021Q1 2022 constant currency revenue, organic* up 11.3% compared to Q1 2021Q1 2022...
Merit Medical Announces Chief Operating Officer Transition
Ronald A. Frost to Retire After More than 30 Years of ServiceNeil Peterson, a 27-Year Company Veteran, Appointed COO SOUTH JORDAN, Utah, April 21, 2022 ...
Merit Medical’s Chief Legal Officer and Corporate Secretary, Brian Lloyd, Receives Corporate Counsel Award from Utah Business Magazine
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of...
Merit Medical Announces Launch of ReSolve® Thoracostomy Tray
Intuitive design facilitates procedural efficiency, supports minimally invasive patient care...
Merit Medical Systems to Announce First Quarter Results on April 27, 2022
SOUTH JORDAN, Utah, April 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary...
Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System
New technology is designed to allow physicians to place SCOUT® reflector at time of biopsy for breast localization under stereotactic and MRI guidance...
Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough...
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020Q4...
Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary...
Merit Medical Announces Agreement in Principle to Settle Class Action Litigation
SOUTH JORDAN, Utah, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary...
Merit Medical Reports Results For Quarter Ended September 30, 2021
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020Q3 2021 GAAP...
Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Prospective, observational study published in CardioVascular and Interventional Radiology 1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month...